Feasibility of platelet marker analysis in ischemic stroke patients and their association with one-year outcome. A pilot project within a subsample of the Stroke Induced Cardiac Failure in Mice and Men (SICFAIL) cohort study

References

• Mohan KM, Wolfe CDA, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence. Stroke 2011;42:1489–1494. doi:10.1161/STROKEAHA.110.602615.
   PubMed Web of Science ®Google Scholar
• Sposato LA, Lam M, Allen B, Shariff SZ, Saposnik G. First-ever ischemic stroke and incident major adverse cardiovascular events in 93 627 older women and men. Stroke 2020;51(2):387–394. doi:10.1161/STROKEAHA.119.028066.
   PubMed Web of Science ®Google Scholar
• Brønnum-Hansen H, Davidsen M, Thorvaldsen P. Long-term survival and causes of death after stroke. Stroke 2001;32(9):2131–2136. doi:10.1161/hs0901.094253.
   PubMed Web of Science ®Google Scholar
• Lim ST, Thijs V, Murphy SJX, Fernandez-Cadenas I, Montaner J, Offiah C, Marquardt L, Kelly PJ, Bath PM, Lim S-Y, et al. Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis. J Neurol 2020;267:3021–3037. doi:10.1007/s00415-020-09932-y.
   PubMed Web of Science ®Google Scholar
• Fahey M, Crayton E, Wolfe C, Douiri A, Quinn TJ. Clinical prediction models for mortality and functional outcome following ischemic stroke: a systematic review and meta-analysis. PLoS One 2018;13:e0185402. doi:10.1371/journal.pone.0185402.
   PubMed Web of Science ®Google Scholar
• Montellano FA, Ungethüm K, Ramiro L, Nacu A, Hellwig S, Fluri F, Whiteley WN, Bustamante A, Montaner J, and Heuschmann PU. Role of blood-based biomarkers in ischemic stroke prognosis: a systematic review. Stroke 2021;52(2):543-551. doi:10.1161/STROKEAHA.120.029232. Epub 2021/ 01/13.
   PubMedGoogle Scholar
• Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, and Michel P. An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology 2012;78:1916–1922. doi:10.1212/WNL.0b013e318259e221.
   PubMed Web of Science ®Google Scholar
• Del Zoppo GJ. The role of platelets in ischemic stroke. Neurology 1998;51:S9–S14. doi:10.1212/WNL.51.3_Suppl_3.S9.
   PubMed Web of Science ®Google Scholar
• Ed Rainger G, Chimen M, Harrison MJ, Yates CM, Harrison P, Watson SP, Lordkipanidzé M, Nash GB. The role of platelets in the recruitment of leukocytes during vascular disease. Platelets 2015;26(6):507–520. doi:10.3109/09537104.2015.1064881.
   PubMed Web of Science ®Google Scholar
• Stoll G, Nieswandt B. Thrombo-inflammation in acute ischaemic stroke — implications for treatment. Nat Rev Neurol 2019;15:473–481. doi:10.1038/s41582-019-0221-1.
   PubMed Web of Science ®Google Scholar
• Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, Ware J, Ruggeri ZM, Jain RK, Folkman J, Wagner DD. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A 2006;103(4):855. doi:10.1073/pnas.0510412103.
   PubMed Web of Science ®Google Scholar
• Matzdorff AC. Evaluation of platelet activation in coronary artery disease – the role of flow cytometry. Transfus Med Hemother 2000;27:237–242. doi:10.1159/000025281.
   Google Scholar
• Rath D, Chatterjee M, Borst O, Müller K, Langer H, Mack AF, Schwab M, Winter S, Gawaz M, Geisler T. Platelet surface expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 is associated with clinical outcomes in patients with coronary artery disease. J Thromb Haemost 2015;13(5):719–728. doi:10.1111/jth.12870.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Stellos K, Geisler T, Lindemann S, May AE, Gawaz M. Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease. Clin Res Cardiol 2010;99(4):227–233. doi:10.1007/s00392-009-0109-y.
   PubMed Web of Science ®Google Scholar
• Rücker V, Heuschmann PU, O’Flaherty M, Weingärtner M, Hess M, Sedlak C, Schwab S, Kolominsky-Rabas PL. Twenty-year time trends in long-term case-fatality and recurrence rates after ischemic stroke stratified by etiology. Stroke 2020;51:2778–2785. Epub 2020/ 08/20. doi:10.1161/STROKEAHA.120.029972.
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019;50:e344–e418.
   PubMed Web of Science ®Google Scholar
• Michelson AD, Barnard MR, Krueger LA, Frelinger AL, Furman MI. Evaluation of platelet function by flow cytometry. Methods 2000;21(3):259–270. doi:10.1006/meth.2000.1006.
   PubMed Web of Science ®Google Scholar
• Heuschmann PU, Montellano FA, Ungethüm K, Rücker V, Wiedmann S, Mackenrodt D, Quilitzsch A, Ludwig T, Kraft P, Albert J, et al. Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: the SICFAIL study. ESC Heart Fail 2021;8:1117–1129. doi:10.1002/ehf2.13145.
   PubMed Web of Science ®Google Scholar
• Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980;58:113–130.
   PubMed Web of Science ®Google Scholar
• Berger K, Weltermann B, Kolominsky-Rabas P, Meves S, Heuschmann P, Bohner J, Neundorfer B, Hense HW, Buttner T. [The reliability of stroke scales. The German version of NIHSS, ESS and Rankin scales]. Fortschr Neurol Psychiatr 1999;67(2):81–93. doi:10.1055/s-2007-993985.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993;24:35–41. doi:10.1161/01.STR.24.1.35.
   PubMed Web of Science ®Google Scholar
• Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965;14:61–65. Epub 1965/ 02/01.
   PubMedGoogle Scholar
• FlowJo™ Software for Windows [software application] Version 10.6. Ashland, OR: Becton, Dickinson and Company; 2019.
   Google Scholar
• Schmitz G, Rothe G, Ruf A, Barlage S, Tschöpe D, Clemetson KJ, Goodall AH, Michelson AD, Nurden AT, Shankey VT, et al. European working group on clinical cell analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998;79:885–896. doi:10.1055/s-0037-1615088.
   PubMed Web of Science ®Google Scholar
• Sperling S, Vinholt PJ, Sprogøe U, Yazer MH, Frederiksen H, Nielsen C. The effects of storage on platelet function in different blood products. Hematology 2019;24(1):89–96. doi:10.1080/10245332.2018.1516599.
   PubMed Web of Science ®Google Scholar
• Rondina MT, Grissom CK, Men S, Harris ES, Schwertz H, Zimmerman GA, Weyrich AS. Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques. Thromb Res 2012;129:729–735.
   PubMed Web of Science ®Google Scholar
• Marquardt L, Ruf A, Mansmann U, Winter R, Schuler M, Buggle F, Mayer H, Grau AJ. Course of platelet activation markers after ischemic stroke. Stroke 2002;33:2570–2574. doi:10.1161/01.STR.0000034398.34938.20.
   PubMed Web of Science ®Google Scholar
• Maurer-Spurej E, Pfeiler G, Maurer N, Lindner H, Glatter O, Devine DV. Room temperature activates human blood platelets. Lab Invest 2001;81(4):581–592. Epub 2001/ 04/17. doi:10.1038/labinvest.3780267.
   PubMed Web of Science ®Google Scholar
• Shea SM, Thomas KA, Spinella PC. The effect of platelet storage temperature on haemostatic, immune, and endothelial function: potential for personalised medicine. Blood Transfus 2019;17:321–330.
   PubMed Web of Science ®Google Scholar
• Hagberg IA, Lyberg T. Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies. Platelets 2000;11:137–150. Epub 2000/ 08/12. doi:10.1080/095371000403071.
   PubMed Web of Science ®Google Scholar
• Linden MD. Platelet flow cytometry. Methods Mol Biol 2013;992:241–262. Epub 2013/ 04/03.
   PubMedGoogle Scholar
• Welch EL, Crooks MG, Hart SP. Agreement between blood draw techniques for assessing platelet activation by flow cytometry. Platelets 2019;30(4):530–534. Epub 2018/ 10/27. doi:10.1080/09537104.2018.1535705.
   PubMed Web of Science ®Google Scholar
• Rondina MT, Grissom CK, Men S, Harris ES, Schwertz H, Zimmerman GA, Weyrich AS. Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques. Thromb Res 2012;129:729–735. Epub 2011/ 12/20. doi:10.1016/j.thromres.2011.11.031.
   PubMed Web of Science ®Google Scholar
• Malinin AI, Atar D, Callahan KP, McKenzie ME, Serebruany VL. Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease. Eur J Pharmacol 2003;462(1–3):139–143. Epub 2003/ 02/20. doi:10.1016/S0014-2999(02)02956-4.
   PubMed Web of Science ®Google Scholar
• McKenzie ME, Malinin AI, Bell CR, Dzhanashvili A, Horowitz ED, Oshrine BR, Atar D, Serebruany VL. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets. Blood Coagul Fibrinolysis 2003;14:249–253. Epub 2003/ 04/16. doi:10.1097/01.mbc.0000046182.72384.ab.
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Malinin AI, Oshrine BR, Sane DC, Takserman A, Atar D, Hennekens CH. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. Thromb Res 2004;113(3–4):197–204. Epub 2004/ 05/14. doi:10.1016/j.thromres.2004.03.002.
   PubMed Web of Science ®Google Scholar
• Taylor ML, Ilton MK, Misso NL, Watkins DN, Hung J, Thompson PJ. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils. Br J Clin Pharmacol 1998;46:139–145. doi:10.1046/j.1365-2125.1998.00766.x.
   PubMed Web of Science ®Google Scholar
• Achilles A, Mohring A, Dannenberg L, Grandoch M, Hohlfeld T, Fischer JW, Levkau B, Kelm M, Zeus T, Polzin A. Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation. J Thromb Haemost 2017;15(3):473–476. Epub 2016/ 12/20. doi:10.1111/jth.13595.
   PubMed Web of Science ®Google Scholar
• Lu Q, Malinauskas RA. Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood. Artif Organs 2011;35:137–144. Epub 2010/ 10/16.
   PubMed Web of Science ®Google Scholar
• Santilli F, Basili S, Ferroni P, Davì G. CD40/CD40L system and vascular disease. Intern Emerg Med 2007;2:256–268. Epub 2007/ 11/29. doi:10.1007/s11739-007-0076-0.
   PubMed Web of Science ®Google Scholar
• Tsai N-W, Chang W-N, Shaw C-F, Jan C-R, Chang H-W, Huang C-R, Chen S-D, Chuang Y-C, Lee L-H, Lu C-H. Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke. Clin Neuropharmacol 2010;33(1):40–45. doi:10.1097/WNF.0b013e3181b8abc6.
   PubMed Web of Science ®Google Scholar
• Vogel S, Bodenstein R, Chen Q, Feil S, Feil R, Rheinlaender J, Schäffer TE, Bohn E, Frick J-S, Borst O, et al. Platelet-derived HMGB1 is a critical mediator of thrombosis. J Clin Invest 2015;125:4638–4654. doi:10.1172/JCI81660.
   PubMed Web of Science ®Google Scholar
• Schneider GS, Rockman CB, Berger JS. Platelet activation increases in patients undergoing vascular surgery. Thromb Res 2014;134:952–956. Epub 2014/ 08/23. doi:10.1016/j.thromres.2014.08.009.
   PubMed Web of Science ®Google Scholar
• Pamukcu B, Lip GYH, Snezhitskiy V, Shantsila E. The CD40-CD40L system in cardiovascular disease. Ann Med 2011;43(5):331–340. Epub 2011/ 01/20. doi:10.3109/07853890.2010.546362.
   PubMed Web of Science ®Google Scholar
• Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 2009;229:152–172. doi:10.1111/j.1600-065X.2009.00782.x.
   PubMed Web of Science ®Google Scholar
• Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92(9):1041–1048. Epub 2003/ 04/05. doi:10.1161/01.RES.0000070111.98158.6C.
   PubMed Web of Science ®Google Scholar
• Tsai N-W, Chang W-N, Shaw C-F, Jan C-R, Chang H-W, Huang C-R, Chen S-D, Chuang Y-C, Lee L-H, Wang H-C, et al. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke. Thromb Res 2009;124:213–218. doi:10.1016/j.thromres.2009.01.012.
   PubMed Web of Science ®Google Scholar
• Garlichs CD, Kozina S, Fateh-Moghadam S, Tomandl B, Stumpf C, Eskafi S, Raaz D, Schmeißer A, Yilmaz A, Ludwig J, et al. Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 2003;34(6):1412–1418. Epub 2003/ 05/24. doi:10.1161/01.STR.0000074032.64049.47.
   PubMed Web of Science ®Google Scholar
• Tsai NW, Chang WN, Shaw CF, Jan CR, Chang HW, Huang CR, Chen SD, Chuang YC, Lee LH, Wang HC, et al. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke. Thromb Res 2009;124:213–218. Epub 2009/ 02/24.
   PubMed Web of Science ®Google Scholar
• Ferro D, Loffredo L, Polimeni L, Fimognari F, Villari P, Pignatelli P, Fuster V, Violi F. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Arterioscler Thromb Vasc Biol 2007;27:2763–2768. doi:10.1161/ATVBAHA.107.152777.
   PubMed Web of Science ®Google Scholar
• Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998;394(6689):200–203. Epub 1998/ 07/22. doi:10.1038/28204.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Jørgensen HS, Raaschou HO, Olsen TS. The influence of age on stroke outcome. The Copenhagen stroke study. Stroke 1994;25:808–813. Epub 1994/ 04/01. doi:10.1161/01.STR.25.4.808.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr., Davis PH, Leira EC, Chang K-C, Bendixen BH, Clarke WR, Woolson RF, Hansen MD. Baseline NIH stroke scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53(1):126–131. Epub 1999/ 07/17. doi:10.1212/WNL.53.1.126.
   PubMed Web of Science ®Google Scholar
• Schuhmann MK, Stoll G, Bieber M, Vögtle T, Hofmann S, Klaus V, Kraft P, Seyhan M, Kollikowski AM, Papp L, et al. CD84 links T cell and platelet activity in cerebral thrombo-inflammation in acute stroke. Circ Res 2020;127:1023–1035. doi:10.1161/CIRCRESAHA.120.316655.
   PubMed Web of Science ®Google Scholar
• Walsh TG, Harper MT, Poole AW. SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4. Cell Signal 2015;27(1):37–46. Epub 2014/ 10/07. doi:10.1016/j.cellsig.2014.09.021.
   PubMed Web of Science ®Google Scholar
• Richard SA, Sackey M, Su Z, Xu H. Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke. Biosci Rep 2017;37:BSR20171104.
   PubMed Web of Science ®Google Scholar
• Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Maruo T, Date I, Yoshino T, Ohtsuka A, Mori S, et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 2011;42:1420–1428. Epub 2011/ 04/09. doi:10.1161/STROKEAHA.110.598334.
   PubMed Web of Science ®Google Scholar
• Ye Y, Zeng Z, Jin T, Zhang H, Xiong X, Gu L. The role of high mobility group box 1 in ischemic stroke. Front Cell Neurosci 2019;13: 127-127. doi:10.3389/fncel.2019.00127.
   Google Scholar
• Yip H-K, Liou C-W, Chang H-W, Lan M-Y, Liu JS, Chen M-C. Link between platelet activity and outcomes after an ischemic stroke. Cerebrovasc Dis 2005;20(2):120–128. doi:10.1159/000086802.
   PubMed Web of Science ®Google Scholar
• Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 1985;260:11107–11114. doi:10.1016/S0021-9258(17)39154-8.
   PubMed Web of Science ®Google Scholar
• Grube MM, Koennecke H-C, Walter G, Meisel A, Sobesky J, Nolte CH, Wellwood I, Heuschmann PU, Berlin Stroke R. Influence of acute complications on outcome 3 months after ischemic stroke. PLoS One 2013;8:e75719–e75719.
   PubMed Web of Science ®Google Scholar